Peptides DB

Research-centric peptide and protocol reference hub

Hexarelin vs Ipamorelin

Updated July 21, 2026 · Reviewed by the PeptidesDB Editorial team

Hexarelin: Research use — not FDA-approvedIpamorelin: Research use — not FDA-approved

A data-driven comparison of Hexarelin and Ipamorelin (also searched as Ipamorelin vs Hexarelin) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.

Verdict

Hexarelin centers on muscle, while Ipamorelin leans toward muscle. On indexed research, Hexarelin is ahead (Hexarelin: 4 studies, Human evidence; Ipamorelin: 4, Preclinical). Choose by goal — and read the primary studies. This is research information, not medical advice.

Key takeaways

  • Hexarelin is strongest for muscle; Ipamorelin for muscle.
  • Evidence: Hexarelin Human evidence (4 studies) vs Ipamorelin Preclinical (4).
  • Both are research-use compounds — not FDA-approved.

Effect profiles, overlaid

HealingMuscleMetabolicNeuroSleepInflammationSkin
HexarelinIpamorelin

At a glance

HexarelinHuman evidence

Examorelin | Synthetic Growth Hormone Secretagogue

Strongest: MuscleStudies: 4Level: Well Studied
IpamorelinPreclinical

Growth Hormone Secretagogue | Selective GHRP

Strongest: MuscleStudies: 4Level: Well Studied

Hexarelin vs Ipamorelin: side-by-side

MetricHexarelinIpamorelin
ClassGHGH
Regulatory statusResearch use onlyResearch use only
Evidence gradeHuman evidencePreclinical
Studies indexed44
Research levelWell StudiedWell Studied
Strongest effectMuscle & body compMuscle & body comp
Healing & recovery1.02.0
Muscle & body comp4.04.0
Metabolic & appetite3.03.0
Neuro & mood2.02.0
Sleep & circadian1.01.0
Inflammation & immune2.02.0
Skin & aesthetics3.03.0

▲ marks the higher community effect score (0–5 perceived-effect signal, not clinical efficacy).

Mechanism & pharmacokinetics

PropertyHexarelinIpamorelin
MechanismSelective GH secretagogue / ghrelin-receptor agonist
RouteSubcutaneous injection
Half-life~2 h

Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.

What is Hexarelin?

### Hexarelin Summary Hexarelin is a synthetic hexapeptide that belongs to the growth hormone secretagogue (GHS) class, known for its ability to stimulate growth hormone release from the pituitary gland. It has been investigated for its potential therapeutic applications in various conditions, including muscle wasting and age-related decline in growth hormone levels.

Full Hexarelin profile, mechanism & studies →

What is Ipamorelin?

### Summary Ipamorelin is a synthetic peptide that acts as a selective agonist of the growth hormone secretagogue receptor, primarily stimulating growth hormone release. Its potential therapeutic applications are being explored in various contexts, including weight management and pain modulation.

Full Ipamorelin profile, mechanism & studies →

Which is better for your goal?

GoalBetter fitWhy
HealingIpamorelin2.0/5 effect signal
MuscleEvenBoth ~4.0/5
MetabolicEvenBoth ~3.0/5
NeuroEvenBoth ~2.0/5
SleepEvenBoth ~1.0/5
InflammationEvenBoth ~2.0/5
SkinEvenBoth ~3.0/5

Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.

Can you stack Hexarelin and Ipamorelin?

People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.

Hexarelin vs Ipamorelin: side effects

Hexarelin

No community-reported effects logged yet.

Ipamorelin

No community-reported effects logged yet.

Anonymous community reports (count = number of reports), not clinical incidence rates.

What the research says

Hexarelin has 4 approved studies indexed (Human evidence), and Ipamorelin has 4 (Preclinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.

Frequently asked questions

Is Hexarelin or Ipamorelin better?

It depends on your goal. Hexarelin is strongest for muscle; Ipamorelin for muscle. Hexarelin has more indexed studies (4). See the goal-by-goal breakdown above.

Is Hexarelin or Ipamorelin better for weight loss?

They score similarly on the metabolic/appetite axis in the community data.

Is Hexarelin or Ipamorelin better for muscle?

Both land close on the muscle & body-composition axis.

Which has more research, Hexarelin or Ipamorelin?

Hexarelin has 4 approved studies indexed (Human evidence); Ipamorelin has 4 (Preclinical). Higher counts mean more to read, not proven superiority.

Can you stack Hexarelin and Ipamorelin?

Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.

What are the side effects of Hexarelin vs Ipamorelin?

Hexarelin: no community-reported effects logged yet. Ipamorelin: none logged yet. These are anonymous reports, not incidence rates — see each profile.

Is Hexarelin or Ipamorelin FDA-approved?

Hexarelin is a research-use compound and is not FDA-approved. Ipamorelin is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.

Is Ipamorelin better than Hexarelin?

For muscle, Ipamorelin has the edge; for muscle, Hexarelin does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.

Comparing related peptides

Regulatory & legal status

Hexarelin and Ipamorelin are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 21, 2026.